Abstract: The invention relates to the production and use of retroviral vectors for cell specific gene transfer, specially to a production method of retroviral vectors containing capsid particles of murine leukemia virus (MLV) and envelope proteins of human immunodeficiency vises (HIV) or simian immunodeficiency viruses (SIV). Said vectors can be used for gene transfer in selected cell types, specially in CD4-positive mammal cells.
Type:
Grant
Filed:
February 27, 1998
Date of Patent:
June 7, 2005
Assignee:
Bundesrepublik Deutschland last Represented by the President of the Paul-Ehrlich-Instituts